中国再生医学（08158）发布公告，因“10并1”基准进行股份合并而削减25.69亿股。
中国再生医学因“10并1”基准进行股份合并而削减25.69亿股
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.